Mobile-health Network Solutions (Class A) (MNDR) carries a Roarable Rating of E (Strong Sell) with 27/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, Mobile-health Network Solutions (Class A) (NASDAQ: MNDR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $0.96 (-2.01% 1D, market cap $3.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, MNDR ranks #648 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), MNDR carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 16.7%, and ROIC of -35.0%. By comparison, AMST (Amesite Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $3.7M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, MNDR leads on earnings multiple (N/A) while MNDR leads on capital efficiency (-35.0% ROIC).
Per MNDR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001976695), Mobile-health Network Solutions (Class A) generated $7.6M in revenue (-45.3% YoY), -$3.4M in net income, and -$4.4M in free cash flow against $9.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 46.6 (NEUTRAL RANGE)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
While MNDR currently carries a cautious 27/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.29) and Max Pain ($1.01) forces dealer call-delta covering toward $34.15.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Mobile-health Network Solutions (Class A) (MNDR) dropped -2.01% to $0.96, trading at 2% of its 52-week range ($0.71 – $32.52). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Benzinga report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
kalkine.ca report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
富途牛牛 report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
StocksToTrade report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Investing.com Nigeria report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Gainers Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 292.6% to $2.37 during Friday's after-market session. The market value of their outstanding shares is at $79.8 million. Capricor Therapeutics
After two and a half years in development, the integrated platform brings doctors, patients, clinical records, pharmacy, and logistics into one connected healthcare ecosystem.Singapore, Singapore--(Newsfile Corp. - Octob
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -45.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MNDR today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MNDR. Explore sector supply chains on /butterfly.
Across 715 tracked Technology securities in the Roarable RQD universe, Mobile-health Network Solutions (Class A) (MNDR) ranks #648 by composite RQD confidence (27/100, grade E) and #682 by equity capitalization ($3.6M). Within this direct 5-issuer industry benchmark cohort, MNDR leads on earnings valuation at N/A trailing P/E, while MNDR leads on capital efficiency and profitability with -35.0% ROIC and 16.7% gross margin. DFSC currently holds the highest overall quantitative score in the immediate peer group at 46/100 (D) compared with MNDR at 27/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MNDR
ACTIVE
Mobile-health Network Solutions (Class A) | E | 27/100 | — | 16.7% | -35.0% | -2.01% | $3.6M | Benchmark Subject |
| AMST Amesite Inc. | E | 32/100 | — | — | -35.0% | +1.48% | $3.7M | /amst-vs-mndr → |
| WCT Wellchange Holdings Company Limited (Class A) | E | 19/100 | — | 42.7% | -35.0% | -6.36% | $3.2M | /wct-vs-mndr → |
| TAOP Taoping Inc. | E | 31/100 | — | 10.9% | -35.0% | +4.14% | $3.1M | /taop-vs-mndr → |
| DFSC DEFSEC Technologies Inc. | D | 46/100 | — | — | — | -13.45% | $3.1M | /dfsc-vs-mndr → |
In its most recent audited fiscal period (FY2025, filed 2025-06-30), Mobile-health Network Solutions (Class A) (MNDR) reported GAAP revenue of $7.6M (-45.3% vs. FY2024 revenue of $14.0M , and -2.9% cumulative change since FY2023) , GAAP net income of -$3.4M, operating cash flow of -$4.4M, and free cash flow of -$4.4M (+32.4% YoY). On the balance sheet, MNDR closed FY2025 with $9.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $7.6M | -$3.4M | -$4.4M | -$4.4M | $9.9M | — |
| FY2024 (FY) | 2024-06-30 | $14.0M | -$15.6M | -$6.4M | -$6.5M | — | — |
| FY2023 (FY) | 2023-06-30 | $7.9M | -$3.2M | -$2.2M | -$2.2M | — | — |
As of 2026-11-03, Mobile-health Network Solutions (Class A) (NASDAQ: MNDR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $0.96 (-2.01% 1D, market cap $3.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, MNDR ranks #648 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), MNDR carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 16.7%, and ROIC of -35.0%. By comparison, AMST (Amesite Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $3.7M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, MNDR leads on earnings multiple (N/A) while MNDR leads on capital efficiency (-35.0% ROIC).
Per MNDR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001976695), Mobile-health Network Solutions (Class A) generated $7.6M in revenue (-45.3% YoY), -$3.4M in net income, and -$4.4M in free cash flow against $9.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
MNDR last traded at $0.96 (-2.01% on volume of 208,886 shares), positioning the stock -25.58% below its 50-day simple moving average ($1.29) and -74.60% below its 200-day simple moving average ($3.78). Across its 52-week range of $0.71 to $32.52, MNDR sits at the 0.8% percentile with a 14-day RSI of 46.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.08).
Mobile-health Network Solutions (Class A) (MNDR) earns a live Roarable RQD composite score of 27/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $0.96 (-2.01% 1D, market capitalization $3.6M).
Is a NASDAQ-listed issuer in the Technology sector, Computer Software: Prepackaged Software industry..0B.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Mobile-health Network Solutions (Class A) (MNDR) reported $7.6M in annual revenue (up from $14.0M in FY2024, -45.3% YoY) and -$3.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($7.9M revenue, -$3.2M net income) through FY2025, MNDR scaled operating cash flow to -$4.4M and free cash flow to -$4.4M, backed by $9.9M in total assets against $0 in total debt.
Sector correlation data beyond the Technology classification is — Upstream and downstream dependencies are — Investors should note the absence of mapped dependencies as a gap in the analysis rather than an indication of resilience.
Real-time company headlines, analyst actions, and sector developments for Mobile-health Network Solutions (Class A) (MNDR) • Click "Debate This Headline" to argue it in the Roar Pit below
Benzinga report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
kalkine.ca report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
富途牛牛 report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
StocksToTrade report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Investing.com Nigeria report covering Mobile-health Network Solutions (Class A) (MNDR) market action, institutional positioning, and fundamental catalysts.
Here is why I am bullish on MNDR here at $0.98: The Singapore platform launch is a referenced operational catalyst, and the stock has shown extreme volume-driven price spikes in recent news coverage.. Compare MNDR's 0.0% operating margin and -35.0% ROIC against the rest of Computer Software: Prepackaged Software. As long as cash conversion holds up, dips toward $0.93 are getting bought.
Both sides have a point here — MNDR's 8/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
I respect the product at Mobile-health Network Solutions (Class A), but the stock at $0.98 is a different story. Negative ROIC of -35%, FCF of -$4.4M in FY 2025, and a Piotroski F-Score of 2/9 indicate weak cash generation and forensic balance sheet risk.. FCF yield is 0.0% and RQD sits at 27/100 (E) — why pay up here when you can wait for next quarter's numbers?
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Gideon Ashmere, Ellis Vennor, Tessa Rookmere, Soren Halewick, Iona Brackenford, Nadia Vellacrest, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your first name and email address below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).
Your $100,000 Virtual Cash Trading Account is active! Add your mobile number below if you want our #1 Weekly Quant Top Pick plus urgent breaking market alerts & SEC Form 4 CEO cluster-buy flashes sent straight to your phone: